T. Rowe Price Health Sciences Fund (PRHSX)
T. Rowe Price Health Sciences Fund (PRHSX) Quote
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
T. Rowe Price Health Sciences Fund (PRHSX) Profile
Family
Category
Inception Date
12-28-1995
Address
Manager
Kris H. Jenner
Manager Start Date
01-13-2000
Profile
The investment seeks long-term capital appreciation.
The fund normally invests at least 80% of assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. While it can invest in companies of any size, the fund invests the majority of assets in large- and mid-capitalization companies.
Net Assets
4.59B
Minimum Investment
$2,500
Morningstar Rating
5 stars
Recent Top Holdings
Alexion Pharmaceuticals
Catamaran Corp
Gilead Sciences
Pharmacyclics
VALEANT PHARMACEUTICALS INTL IN
UnitedHealth Group
Regeneron Pharmaceuticals
Incyte
Covidien plc.
Merck & Company
Catamaran Corp
Gilead Sciences
Pharmacyclics
VALEANT PHARMACEUTICALS INTL IN
UnitedHealth Group
Regeneron Pharmaceuticals
Incyte
Covidien plc.
Merck & Company
T. Rowe Price Health Sciences Fund (PRHSX) News
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
T. Rowe Price Health Sciences Fund (PRHSX) additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
Current Market
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
